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 ABSTRACT 
 
Applications of Asymmetric Allylation Reactions Towards  
Natural Product Synthesis 
 
Philip R. Harsh 
 
 
A short asymmetric synthesis of (R)-(+)-Goniothalamin oxide was developed and 
synthesized using a Leighton asymmetric allylation reaction and Grubbs ring-closing 
metathesis.  (R)-(+)-Goniothalamin oxide is a styryl lactone that exhibits anti-cancer 
activity against a variety of cancer cell lines including MCF-7, T47D, and MDA-MB-
231.  The methododology of asymmetric allylation is also demonstrated on intermediates 
of RK-397, which is a 32-membered oxopolyene macrolide with anti-cancer activity.  
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CHAPTER I 
 
1.1 Introduction: Previous Asymmetric Allylation Reactions 
 
 Asymmetric allylation reactions have been the focus of several research groups 
for the past few decades.  Throughout this period, the groups of Brown, Keck, Roush, and 
Leighton have most notably developed various asymmetric allylation reagents that have 
shown to add allyl groups with high enantioselectivity for a variety of aldehydes.  
Scheme 1 shows a generic asymmetric allylation of an achiral aldehyde where the chiral 
reagent selectively forms one of the two possible enantiomeric homoallylic alcohols. 
 
Scheme 1: Generic Chiral Allylation Reaction 
R H
O
R
OH
Chiral allyl-anion or
R
OH
equivalent  
 
The reaction conditions of each type of asymmetric allylation reaction are quite 
different in several aspects including: catalytic vs. stoichiometric, chiral reagents vs. 
chiral Lewis acid, and reaction conditions (time/temperature).  Outlined in Scheme 2 are 
the different reaction types and conditions for the most common asymmetric allylation 
reagents. 
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Scheme 2: Common Asymmetric Allylation Reactions 
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 Brown was one of the first to recognize the potentiality of this reaction.  Brown 
and co-workers explored the asymmetric allylation reactions using a chiral allylborane 
reagent, Ipc2Ballyl (Scheme 3).  The Brown reagent, Ipc2Ballyl, is made by a three-step 
procedure that begins with the hydroboration of the natural product α-pinene, from which 
it draws its chirality.1 
 
Scheme 3: Brown Asymmetric Allylation 
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R
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 The Brown allylation of achiral aldehydes, in general, affords secondary 
homoallylic alcohols with high enantioselectivity (85-99 %ee) for a variety of substrates.  
The reaction can be dependent upon temperature under -78 °C being the most common 
reaction condition. Similarly, it is important to generate the Brown reagent without the 
presence of any magnesium salts, which can lower the enantioselectivity/reactivity of the 
reaction.  Thus in the absence of magnesium salts, the typical allyborylation of an 
aldehyde can occur almost instantaneously at -78 °C.    
 Brown also showed that the allylation of aldehydes proceeded through a chair-like 
Zimmerman-Traxler transition state.  Thus E-substituted allyl reagents give anti-
homoallylic alcohols and Z-substituted reagents give syn-homoallylic alcohols.  Figure 1 
shows Brown’s proposed transition state for the allylation where the R-group of the 
aldehyde occupies the equatorial position allowing minimal steric interactions between 
the axial isopinocamphenyl (Ipc) ligands and the allyl group.2 
 
Figure 1: Transition State of Brown Allylation 
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 At about the same time as the Brown group, the Roush group also developed an 
asymmetric allylation reagent.  Roush and coworkers utilized a boron-based reagent for 
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asymmetric allylation reactions; however, it is quite different in many aspects from the 
Brown reaction.  Scheme 4 shows a typical asymmetric allylation of an aldehyde with the 
Roush’s allyl boronate complex. 
 
Scheme 4: Roush Asymmetric Allylation 
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The allyl boronate reagent that Roush employs in the allylation reaction is considerably 
more stable than the allyl-diisopinocamphenyl reagent that Brown used.  This has very 
important advantages for allowing the reagent to be purified by distillation, if necessary.  
The major downfall of the Roush’s allylation reaction is that it produces homoallylic 
alcohols with lower enantioselectivities (70-90 %ee) compared to Brown’s.  The 
enantioselectivities are diminished by the presence of water and thus the addition of 4 Å 
molecular sieves is important to achieve the highest stereoselectivity.3 
Figure 2: Transition State of Roush Asymmetric Allylation 
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Roush proposed that the selectivity in the allyborylation reactions was due to the 
favored transition state that minimized the lone-pair/lone-pair interactions between the 
aldehyde and the ester carbonyl.  Figure 2 shows these transition states and the desired 
enantioselective product.3 
Leighton discovered that silicon could also be used as an allylation reagent when 
it was constrained in a five-membered ring by 1,2-aminoalcohols, 1,2-diols, and 1,2-
diamines.  He suggests this is due to the increased Lewis acidity imparted by the 
heteroatoms and ring strain.  His hypothesis is supported by the fact that the simple 
trichloroallylsilane has insufficient Lewis acidity for uncatalyzed allylation of aldehydes.  
Scheme 5 outlines a typical Leighton allylation using a chiral silicon 1,2-diamine reagent. 
 
Scheme 5: Leighton Asymmetric Allylation 
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Leighton and coworkers optimized the silicon reagent (shown in reaction above) 
by replacing an original benzyl groups with a para-substituted bromo-benzyl groups.  
This transformation of the silicon reagent was very important to increase the 
enantioselectivity (90-99 %ee) and yields (70-95%) for the allylation of aliphatic, 
aromatic, and conjugated aldehydes.4  Leighton and coworkers extended applications of 
the reagent by applying onto chiral aldehydes.  Scheme 6 outlines a typical Leighton 
allylation using both enantiomers of the silicon reagent (1) on a chiral substate.  Thus, 
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Leighton methodology demonstrates high reagent control over substrate control for 
aldehydes with chiral centers in the beta-position.4 
 
Scheme 6: Leighton Allylation of Chiral Aldehydes 
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 Keck and Carreira research groups have explored the development of a catalytic 
asymmetric allylation reaction.  The key difference between the approaches of these two 
research groups is that Keck employs an allyl-tin based reagent while Carreira uses an 
allyl-silane reagent.  The scheme 7 shows the two catalytic asymmetric allylation 
reactions to give homoallylic alcohols.5,6,7 
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Scheme 7: Keck and Carreira Catalytic Asymmetric Allylations 
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Both reactions are catalytic in chiral Lewis acids, which are generated by the 
titanium specie and the chiral ligand (BINOL) that is available commercially in both 
enantiomers.  It is important to note that in Carreira allylation reactions, the addition of a 
small amount of CH3CN is important to keep the polymeric TiF4 soluble.  The 
enantioselectivities for both reactions are competitive with each other with 
enantioselectivities in the range of 70 to 95 %.   
Another important factor to mention about each of the reactions is the toxicity of 
the tin reagent compared to silicon reagent.  The health effects of tin can range from 
acute to long term depending on the exposure and type of the tin reagent one is exposed 
to.  Triethylstannane has been recognized as the most dangerous form of tin due to the 
short hydrogen bonds.  Tin compounds become considerably less toxic as the hydrogen 
bond is lengthened.8   Health effects that are associated with tin are: liver damage, brain 
damage, and malfunction of the immune system.8 
 Silicon, on the other hand, is relatively less harmful to humans.  Silicon 
concentrates in no particular organ of the body but is found in the skin and tissues.  
Silicon may cause health affects including: respiratory tract infection and irritation of 
skin and eyes.9  
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1.2 Previous approaches to Goniothalamin oxide/analogues 
 
 There have been several syntheses of Goniothalamin and Goniothalamin oxide 
derivatives.  Goniothalamin was first isolated in 1967 from the bark of Cryptocarya 
caloneura and was assigned to have (S)-stereochemistry.10  However, the stereochemistry 
was revised many years later to the (R) configuration.  Several derivatives of 
Goniothalamin have been discovered from a variety of tropical/subtropical plants 
including; Cryptocarya moschata,11 Bryonopsis laciniosa,12 and various Goniothalamus13 
species.  These natural products have shown cytotoxicity on a variety of cells lines 
including: MCF-7, T47D, and MDA-MB-231 (breast carcinoma); HeLa (human cervical 
carcinoma); HL-60 (leukemia carcinoma); Caov-3 (ovarian carcinoma).  Figure (3) 
shows a variety of Goniothalamin-based derivatives.14 
 
Figure 3: Goniothalamin-Based Derivatives 
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 There are two total syntheses of (R)-(+)-goniothalamin and (R)-(+)-goniothalamin 
oxide that have been recently reported by Marko and Bose respectively.14,15  Note that 
several other research groups have synthesized Goniothalamin and Goniothalamin 
analogues but the emphasis of this thesis will be on the two syntheses mentioned above 
with relevance to their work.15  Marko and coworkers, employed a sulfoxide-modified 
Julia olefination starting from optically pure glycidol ether.  In contrast, Bose and 
coworkers utilized a ring-closing metathesis and Jacobsen’s hydrolytic kinetic resolution 
of a racemic epoxide. 
 In 2006, Marko and coworkers completed the total synthesis of (R)-(+)-
goniothalamin and (R)-(+)-goniothalamin oxide in five and six steps (51-55% overall 
yield) respectively (Scheme 8). 
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Scheme 8: Retrosynthesis Analysis of Marko’s Synthesis 
O
Ph
O
O
O
O
SPh
O
Ph
O
OP
O
OP
O
(R)-(+)-goniothalamin
O
Ph
O
O
(R)-(+)-goniothalamin oxide
O
Ph
O
(R)-(+)-goniothalamin
epoxidation
sulfoxide-
modified Julia
olefination
1
2
34
5
5 6  
 
 (R)-(+)-goniothalamin was completed by a connection at the C6-C7 bond by 
employing a sulfoxide modified Julia olefination on aldehyde 4 and sulfoxide 3.  The 
aldehyde 4 was assembled from the protected diene 2 by a ring closing metathesis.  Ring 
opening and acylation of the optically pure protected glycidol 1 afforded the protected 
diene 2.  (R)-(+)-goniothalamin oxide 6 was accomplished by epoxidation of (R)-(+)-
goniothalamin 5.14 
 Bose’s synthesis (Scheme 9) achieved the natural products of (R)-(+)-
goniothalamin and (R)-(+)-goniothalamin oxide in six steps with 65% overall yield. 
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Scheme 9: Retrosynthesis Analysis of Bose’s Synthesis 
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 Bose synthesized the two natural products shown in Scheme 9 by a ring closing 
metathesis of triene 4 using Grubbs’ 1st generation catalyst.  The triene 4 was afforded by 
an acylation of alcohol 3 which was synthesized from the chiral epoxide 2.  The chiral 
epoxide 2 was furnished by using an olefination followed by epoxidation of trans-
cinnamaldehyde 1 followed by a Jacobsen hydrolytic kinetic resolution (HKR) of the 
racemic epoxide.  The downfall of using Jacobsen HKR is that half of the starting 
epoxide is converted to a chiral epoxide with the opposite stereochemistry of the natural 
product.16  Compound 6 was synthesized by using Jacobsen’s expoxidation from 5. 
 
1.3 Total synthesis of (R)-(+)-goniothalamin oxide 
 Our approach for the total synthesis of (R)-(+)-goniothalamin oxide is much 
similar to Bose’s synthesis, in that we go through the same homoallylic alcohol.  The 
retrosynthesis in Scheme 10 shows the similarities and the differences in the two 
syntheses.
 12 
Scheme 10: Retrosynthetic Approach Towards (R)-(+)-goniothalamin oxide 
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 Our route to (R)-(+)-goniothalamin oxide also relies upon a ring-closing 
metathesis of the diene 4 using the Grubbs I catalyst.  Acylation of the secondary alcohol 
of epoxide 3a could afford the diene 4 that would be used in the ring-closing metathesis.  
Epoxide 3a could be prepared by a Leighton allylation of trans-cinnamaldehyde 1 
followed by an diastereoselective epoxidation of the internal double bond of the allyl-
product 2.   
Scheme 11: Stereoselective Synthesis of Epoxide 3a & 3b 
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The total synthesis of (R)-(+)-goniothalamin oxide was accomplished by using 
commercially available starting material trans-cinnamaldehyde 1.  Enantioselective 
allylation of trans-cinnamaldehyde 1 was completed using the (S,S)-Leighton reagent 7 to 
furnish secondary alcohol 2 in 95% yield with excellent stereoselectivity.  The 
stereoselective epoxidation of the internal double bond was completed by using 
VO(acac)2/t-BuOOH in refluxing benzene to diastereoselectively furnish the undesired 
product (3b) in the ratio of 10:1 (Scheme 11).  However, the desired product (3a) could 
be furnished at a greater yield and higher diasteroselectivity using a mCPBA epoxidation 
of 2. 
 It is important to note that the mixture of diastereomers were inseparable by flash 
chromatography at this point, but could be cleanly separated following the acylation 
reaction (Scheme 12). 
Scheme 12: Acylation of epoxides 
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 Thus, the mixture of epoxides was acylated using acrylic acid, DMAP/DCC in 
CH2Cl2 (70% yield).  The mixture of acylated products 4a/4b was then easily separated 
by flash chromatography to give two pure diastereomers.  The (1R,2´S,3´S) diastereomer 
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4a was used to complete the total synthesis of (R)-(+)-goniothalamin oxide by means of a 
ring-closing metathesis (Scheme 13), which was induced upon exposure of 4a to the 
Grubbs 1st generation catalyst. 
Scheme 13: Ring-Closing Metathesis of Diene 4a 
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 The other diastereomer (1R,2´S,3´S)-4b was also subject to a ring-closing 
metathesis using Grubbs 1st generation catalyst (Grubbs I) to give the diastereomeric 
product of (R)-(+)-goniothalamin oxide 6 (Scheme 14).  This diastereomer could be 
prepared in a slightly higher yield replacing the diastereoselective directed epoxidation of 
2 with an unselective mCPBA epoxidation. 
Scheme 14: Ring-Closing Metathesis of Diene 4b 
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CH2Cl2
O
O
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O
O
O
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-5,6-dihydro-2H-pyran-2-one 6
 
 The total synthesis of (R)-(+)-goniothalamin oxide 5 and (1R,2'S,3'S)-3-
phenyloxiran-2-yl)-5,6-dihydro-2H-pyran-2-one 6 were completed in four steps in 35% 
and 33% overall yield respectively.  Both syntheses provide material with physical and 
spectral date that matched the data reported in the literature.14 
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CHAPTER II 
 
2.1 Background of Oxopolyene Macrolide Antibiotic RK-397  
 
 RK-397 (Figure 4) is a 32-membered oxopentaene macrolide antibiotic that was 
isolated and characterized from a Japanese soil bacterium in 1993 by Osada and co-
workers.16  The macrolide processes antifungal properties along with potent oncotoxicity 
in a variety of cancer cell lines.17  Due to this interesting activity and the unique structure 
of RK-397, many research groups have completed total and formal syntheses of this 
compound including: McDonald18, Denmark19, Sammakia20 and O’Doherty.20 
 
Figure 4: RK-397, 32-membered oxopentaene antibiotic 
O
OH OH OH OH OH OH
OH
OH
O
RK-397  
 
 O’Doherty’s formal synthesis of RK-397 utilizes two dienoate asymmetric 
hydration reaction sequences (7 to 6 and 8 to 5) to set the initial asymmetry of the 
convergent synthesis.  In addition, several highly diastereoselective reactions were used 
to control the remaining stereocenters of RK-397.  These reactions included two reagent 
controlled Leighton allylation reactions, as well as three substrate controlled 
intramolecular hydration reactions and one substrate controlled aldol reaction (4 + 5 to 3, 
Scheme 15).21 
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Scheme 15: Retrosynthesis of RK-397 
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In addition to developing new reaction sequences for the practical syntheses of 
biologically important molecules, the O’Doherty group has also been interested in 
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developing a de novo asymmetric approach to stereochemically complex chiral molecules 
by using an asymmetric catalysis to install all the chiral centers from achiral starting 
materials (i.e., 7 and 8, Scheme 15).  If the two Leighton allylation reactions in the 
O’Doherty route could be replaced with catalytic asymmetric allylation reactions, then 
this route to RK-397 would become truly a de novo asymmetric approach.  Thus, we 
decided to try to incorporate the newly developed Krische asymmetric allylation as an 
alternative to the two Leighton allylation reactions.  At the outset, it was decided this 
reaction would be conducted in collaboration with the Krische group. 
 
Scheme 16: Synthesis of Leighton Allylation Intermediates Towards RK-397 
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Outlined in Scheme 16 are the two key sequences (a and b) that contain the 
relevant Leighton allylation steps.  In addition, to having the advantage of replacing 
stoichiometric reagents with catalytic reagents, the incorporation of two Krische 
allylation reactions will eliminate the need for two additional oxidation reactions.   
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2.2 Outline of Krische Catalytic Asymmetric Allylation 
  
Krische and coworkers have developed a transfer hydrogenation/allylation 
reaction that employs an iridium catalyst generated in situ to couple allyl acetate to 
allylic, aliphatic, and benzylic alcohols to furnish homoallylic alcohol products with high 
levels of asymmetric induction (Scheme 17).22 
 
Scheme 17: Ir-Catalyzed Transfer Hydrogenative Allylation of Allylic Alcohols 
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 The Ir-catalyzed transfer hydrogenative allylation of alcohols shown above is very 
important in the synthesis of a wide range of diverse natural product architectures.  By 
using this type of catalytic asymmetric allylation reaction, one is able to eliminate the 
stoichiometric amount of metallic waste that is associated with other types of asymmetric 
allylations and oxidation/reductions steps that may occur in a total synthesis.  In addition, 
by eliminating the use of an oxidation steps it also reduces the amount of waste 
generated.  Thus the Krische allylation could be a very valuable tool towards the total or 
formal synthesis of a natural product.   
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2.3 Synthesized Intermediates for Krische Allylation and Future Work 
 
 A series of alcohol intermediates, aldehyde standards and homoallylic alcohol 
products were synthesized in preparation for the Krische collaboration (scheme 18 and 
19).  The two homoallylic alcohols 13 and 14 were prepared from Dibal-H reduction of 
the known esters 9 and 11 (Scheme 18).  Samples of 300 mg of 13 and 150 mg of 14 
were prepared and sent to the Krische labs at the University of Texas-Austin. 
 
Scheme 18: Synthesized Alcohols 
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Scheme 19: Synthesized Aldehydes 
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Because the Krische allylation reaction generates aldehyde intermediate, the two 
aldehydes 6 and 15 were prepared by MnO2 and Dess-Martin oxidation respectively 
(scheme 19).  Finally, the two aldehydes were asymmetrically allylated to prepare 
samples of the two sets of two diastereomeric homoallylic alcohols 10a and 10b as well 
as 12a and 12b using the enantiomeric Leighton reagents (Scheme 20).  Thus samples of 
10 mg of 10a, 15 mg of 10b, 10 mg of 12a and 10 mg of 12b were prepared and sent to 
the Krische labs at the University of Texas-Austin.  These efforts are on going and will 
be reported in due course. 
Scheme 20: Leighton Allylation Products 
OTBS
H
O
OTBS
OH
(S,S)-Leighton
Reagent
OTBS
OH
(R,R)-Leighton
Reagent
OTBS
O O
Ph
O
OTBS
O O
Ph
OH
OTBS
O O
Ph
OH
H
(S,S)-Leighton
Reagent
(R,R)-Leighton
Reagent
6
15
10a
10b
12a
12b  
 
 
 
 21 
Conclusion: 
 In conclusion, a short total synthesis of (R)-(+)-Goniothalamin Oxide has been 
completed using a Leighton asymmetric allylation reaction and a Grubbs ring-closing 
metathesis.  Also intermediate alcohols and aldehydes of RK-397 were synthesized for a 
collaboration to complete a catalytic asymmetric allylation.  
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CHAPTER III   
 
Experimental Section 
 
 
3.1 General Information: Instrumentation, Materials, Manipulation  
 
 1H and 13C NMR spectra were recorded on a 600 or 270 MHz spectrometer.  Chemical 
shifts are reported relative to internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 
ppm) or CD3OD (δ 4.89 ppm) for 1H NMR and CDCl3 (δ 77.1 ppm) or CD3OD (δ 49.15 
ppm) for 13C NMR.  Infrared (IR) spectra were obtained on a FT-IR spectrometer.  
Optical rotations were measured with a digital polarimeter in the solvent specified.  
Melting points were determined with a standard melting point apparatus and are 
uncorrected.  Flash column chromatography was performed on 60-200 mesh silica gel. 
Analytical thin-layer chromatography was performed with precoated glass-backed plates 
and visualized by quenching of fluorescence and by charring after treatment with p-
anisaldehyde or phosphomolybdic acid (PMA) or potassium permanganate stain 
(KMnO4).  Rf values are obtained by elution in the stated solvent ratios (v/v).  Ether, 
THF, methylene chloride and triethylamine were dried by passing through activated 
alumina column with argon gas pressure. Commercial reagents were used without 
purification unless otherwise noted. Air and/ or moisture- sensitive reactions were carried 
out under an atmosphere of argon/nitrogen using oven-dried glassware and standard 
syringe/septa techniques.  HPLC analyses were carried out using a chiral column eluting 
(flow rate = 1.0 mL/min) with Argon-degassed HPLC grade solvents.  Detection was 
done by UV. 
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(3R,E)-1-Phenylhexa-1,5-dien-3-ol (2): 
 
OH
 
 
To a solution of E-cinnamaldehyde 1 (478 mg, 3.62 mmol) in 5 mL of CH2Cl2 at -10 °C 
was added (S,S)-Leighton Reagent (1.0 g, 1.81 mmol) in 4 mL of CH2Cl2 at -10 °C.  
After stirring for 5 min the solution was stored in a freezer for 20 hrs.  The reaction was 
quenched with 1N HCl (10%), sat. NH4Cl aqueous solution, and then diluted with EtOAc 
then passed through celite.  The aqueous layer was extracted with EtOAc and the 
combined organic layers were washed with brine, dried over anhydrous Na2SO4, and 
concentrated to afford the crude product.  Flash chromatography on silica gel (8:2 (v/v) 
hexane/EtOAc) provided compound 2 (600 mg, 95% yield) as a yellow oil.  Rf = 0.37 
(8:2 (v/v) hexane/EtOAc). Spectral data gave a satisfactory match to previous reports.23 
[α]25D = 30° (c 1.6, CHCl3);  IR (neat, cm-1) 3348, 1640, 1493, 964, 913, 746, 691; 1H 
NMR (CDCl3, 600 MHz) 7.39 (m, 2H), 7.32 (m, 2H), 7.24 (m, 1H), 6.62 (d, J = 15.6 Hz, 
1H), 6.18 (dd, J = 15.6, 6.6 Hz, 1H), 5.87 (dddd, J = 17.4, 10.2, 7.2, 7.2 Hz, 1H), 5.19 
(m, 2H), 4.37 (dd, 6.6, 6.6 Hz, 1H), 2.42 (m, 2H), 1.85 (s, 1H); 13C NMR (CDCl3, 600 
MHz) δ 136.6, 134.0, 131.5, 130.4, 128.5, 127.6, 126.4,118.5, 71.7, 42.0; HRMS (CI) 
calcd for [C12H14O + Na]+: 197.0945, Found: 197.0942 
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(1R,2´S,3´S)-3´-phenyloxiran-2´-yl)but-3-en-1-ol (3a): 
 
OH
O
 
 
To a solution of product (1R,E)-1-phenylhexa-1,5-dien-3-ol 2 (150 mg, 0.861 mmol) in 7 
mL of benzene was added VO(acac)2 (3 mg, 12 µmol) to produce a green colored 
solution. After 10 min of stirring t-BuOOH (85 mg, 0.947 mmol) was added to the 
solution which was accompanied by a color change to a pale yellow/orange color.  The 
reaction was quenched with a sat. NaHCO3 aqueous solution.  The layers were separated. 
The aqueous layer was extracted with EtOAc and the combined organic layers were 
washed with brine, dried over anhydrous Na2SO4, and concentrated to afford crude 
product.  Flash chromatography on silica gel (9:1 (v/v) hexane/EtOAc) provided 
compound 3a (119 mg, 71% yield) as a colorless oil. Spectral data gave a satisfactory 
match to previous reports.24  Rf = 0.30 (8:2 (v/v) hexanes:EtOAc);  [α]25D = 26 ° (c 0.4, 
CHCl3); IR (neat, cm-1) 3439, 1642, 917; 1H NMR (CDCl3, 270 MHz) 7.32 (m, 5H), 5.90 
(ddt, J = 16.8, 10.2, 7.2, 7.2 Hz, 1H), 5.17 (m, 2H), 3.99 (dddd, J = 4.8, 4.8, 4.0, 4.0 Hz, 
1H), 3.97 (d, J = 1.8 Hz, 1H), 3.10 (dd, J = 3.0, 1.8 Hz, 1H), 2.35(m, 2H), 2.03(m, 1H); 
13C NMR (CDCl3, 600 MHz) δ 136.8, 133.4, 128.5, 128.3, 125.7, 118.4, 68.3, 64.2, 55.0, 
37.9; HRMS (CI) calcd for [C12H14O2 + Na]+: 213.0894, Found: 213.0892 
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(1R,2´S,3´S)-3´-phenyloxiran-2´-yl)but-3-enyl acrylate (4a): 
O
O
O
 
To a solution of product (1R,2´S,3´S)-3´-phenyloxiran-2´-yl)but-3-en-1-ol 3a (120 mg, 
0.629 mmol) in 10 mL of CH2Cl2 was added acyrilic acid (188 mg, 2.61 mmol), DCC 
(538 mg, 2.61 mmol), and DMAP (4 mg) at room temperature. After stirring for 6 hrs the 
reaction was diluted with ether, passed through celite, and extracted with 1M aqueous 
NaHSO4 and then sat. aqueous NaHCO3.  The combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, and concentrated.  Flash chromatography on 
silica gel (9.5:0.5 (v/v) hexanes/EtOAc) provided compound 4a (92.2 mg, 60% yield) as 
a colorless oil.  Rf = 0.59 (8:2 (v/v) hexanes:EtOAc); [α]25D = 61° (c 0.4, CHCl3); IR 
(neat, cm-1) 1731, 1240, 1186, 1046; 1H NMR (CDCl3, 600 MHz) 7.30 (m, 5H), 6.43 (dd, 
J = 17.3, 1.5 Hz, 1H), 6.12 (dd, J = 17.1, 10.4 Hz, 1H), 5.84 (m, 2H), 5.16 (m, 2H), 4.99 
(ddd, J = 7.2, 5.2, 3.2 Hz), 3.94 (d, J = 2.0 Hz, 1H), 3.07 (dd, J = 5.7, 2.0 Hz, 1H), 2.57 
(m, 2H); 13C NMR (CDCl3, 600 MHz) δ 165.3, 136.6, 132.4, 131.3, 128.5, 128.3, 128.1, 
125.6, 118.5, 72.1, 61.8, 57.3, 35.8 HRMS (CI) calcd for [C12H14O2 + Na]+: 267.0999, 
Found: 267.0997 
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(R)-(+)-goniothalamin oxide (5): 
O
O
O
 
To a solution of product (1R,2´S,3´S)-3´-phenyloxiran-2´-yl)but-3-enyl acrylate 4a (25 
mg, 0.10 mmol) in 7 mL of CH2Cl2 was added Grubbs (I) catalyst (8 mg, 0.010 mmol) at 
room temperature.   After stirring for 4 hrs at reflux the reaction was concentrated.  Flash 
chromatography on silica gel (7:3 (v/v) hexane:EtOAc) provided compound 5 (17 mg, 
77% yield) as a dark oil. (Note: Color caused by Grubbs catalyst)  Rf = 0.086 (8:2 (v/v) 
hexanes:EtOAc).  Spectral data gave a satisfactory match to previous reports.25 [α]25D 
=100° (c 0.4, CHCl3); IR (neat, cm-1) 1724, 1247, 1041, 815; 1H NMR (CDCl3, 600 
MHz) 7.34(m, 5H), 6.94 (ddd, J = 8.7, 4.9, 3.7 Hz, 1H), 6.08 (ddd, J = 9.6, 3.7, 1.7, 1H), 
4.45 (ddd, J = 9.1, 5.8, 5.8 Hz, 1H), 3.89 (d, J = 1.9 Hz, 1H), 3.27 (dd, J = 5.6, 1.9 Hz, 
1H), 2.59 (m, 2H); 13C NMR (CDCl3, 600 MHz) δ 163.7, 144.2, 135.7, 128. 7, 128.6, 
125.7, 121.6, 77.1, 61.5, 57.3, 25.9 HRMS (CI) calcd for [C12H14O2 + Na]+: 217.0786 
Found: 217.0865 
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(1R,2´R,3´R)-3´-phenyloxiran-2´-yl)but-3-enyl acrylate (4b): 
O
O
O
 
To a solution of product (1R,2´R,3´R)-3´-phenyloxiran-2´-yl)but-3-en-1-ol 3b (120 mg, 
0.629 mmol) in 10 mL of CH2Cl2 was added acyrilic acid (188 mg, 2.61 mmol), DCC 
(538 mg, 2.61 mmol), and DMAP (4 mg) at room temperature. After stirring for 6 hrs the 
reaction was diluted with ether, passed through celite, and extracted with 1M aqueous 
NaHSO4 and then sat. aqueous NaHCO3.  The combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, and concentrated.  Flash chromatography on 
silica gel (9.5:0.5 (v/v) hexanes/EtOAc) provided compound 4b (92.2 mg, 60% yield) as 
a colorless oil. Rf = 0.58 (8:2 (v/v) hexanes:EtOAc); IR (neat, cm-1) 1731, 1406, 1373, 
1240, 1186, 1046, 984; 1H NMR (CDCl3, 270 MHz) 7.29 (m, 5H), 6.48 (dd, J = 17.3, 1.5 
Hz, 1H), 6.17 (dd, J = 17.0, 7.0 Hz, 1H), 5.83 (m, 2H), 5.14 (m, 1H), 4.98 (dd, J = 12.6, 
6.7, 1H), 3.79 (d, J = 2.0 Hz, 1H), 3.17 (dd, J = 5.9, 2.0 Hz, 1H), 2.54 (m, 2H); 13C NMR 
(CDCl3, 600 MHz) δ 165.6, 136.5, 132.4, 131.6, 128.7, 128.6, 128.4, 125.8, 119.1, 73.1, 
62.7, 56.7, 36.2   
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(R)-6-((2R,3R)-3-phenyloxiran-2-yl)-5,6-dihydro-2H-pyran-2-one (6): 
O
O
O
 
To a solution of product (1R,2´R,3´R)-3´-phenyloxiran-2´-yl)but-3-enyl acrylate 4b (25 
mg, 0.10 mmol) in 7 mL of CH2Cl2 was added Grubbs (I) catalyst (8 mg, 0.010 mmol) at 
room temperature.   After stirring for 4 hrs at reflux the reaction was concentrated.  Flash 
chromatography on silica gel (7:3 (v/v) hexane:EtOAc) provided compound 6 (17 mg, 
77% yield) as a dark oil. Rf = 0.087 (8:2 (v/v) hexanes:EtOAc); IR (neat, cm-1) 1724, 
1386, 1247, 1041, 815, 698; 1H NMR (CDCl3, 270 MHz) 7.33(m, 5H), 6.92 (ddd, J = 
8.7, 5.4, 3.0 Hz, 1H), 6.08 (ddd, 9.9, 2.6, 1.7 1H), 4.68 (ddd, J = 8.7, 4.7, 3.7 Hz, 1H), 
4.08 (d, J = 1.9 Hz, 1H), 3.24 (dd, J = 3.7, 1.9 Hz, 1H), 2.62 (m, 2H); 13C NMR (CDCl3, 
600 MHz) δ 162.8, 143.9, 135.9, 128.6, 128.6, 125.7, 121.6, 75.1, 62.1, 55.0, 26.2 
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(−)-(E,4S,5S)-Ethyl 5-(tert-butyldimethylsilyloxy)-4,6-dimethylhept-2-enoate (9):  
OEt
OTBS O
 
The δ-hydroxy enoate (200 mg, 1.0mmol) was added to a flask with CH2Cl2 (1.0 mL) 
followed by addition of 2,6-lutidine (233 µL, 2.0 mmol).  The mixture was allowed to 
cool to 0oC in an ice bath.  Then TBSOTF (253 µL, 1.1 mmol) was added slowly via 
syringe and the reaction was allowed to warm to RT and stir 2 hours.  The reaction was 
then quenched with the addition of Et2O (4mL) followed by washing with a saturated 
aqueous solution of CuSO4 (1 mL).  The layers were separated and the organic layer was 
washed with brine (1.5mL).  The organics were then dried over Na2SO4 and concentrated 
en vacuo.  The crude mixture was purified immediately by flash column chromatography 
over silica gel (5% CH2Cl2/5% Et2O/Hexanes) to yield TBS-protected enoate 9 (276 mg, 
88%) as a clear, colorless oil.  Spectral data gave a satisfactory match to previous 
reports.26 [α]25 D = − 27 (c = 1.5, CH2Cl2); 1H NMR (CDCl3, 270 MHz) δ 6.97 (dd, J = 
15.8, 7.9 Hz, 1H), 5.76 (d, J = 15.8 Hz, 1H), 4.18 (q, J = 7.2 Hz, 2H), 3.37 (dd, J = 4.9, 
4.9  Hz, 1H), 2.51 (m, 1H), 1.71 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.03 (d, J = 6.9 Hz, 
3H), 0.90 (s, 9H), 0.87 (d, J = 6.7 Hz, 3H), 0.85 (d, J = 6.7 Hz, 3H), 0.04 (s, 3H), 0.03 (s, 
3H). HRMS (ESI) calcd for [C171H34O3Si + Na]+: 337.2175  Found: 337.2180. 
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(−)-(E,4S,5S)-5-(tert-butyldimethylsilyloxy)-4,6-dimethylhept-2-en-1-ol (13): 
OH
OTBS
 
The ester 9 (2.13 g, 6.78 mmol) was dissolved in THF (6.8 ml) and cooled to −78 oC.  
Next was added 2.2 equiv Dibal-H (14.91 ml of 1M hexane solution) via syringe.  The 
reaction was allowed to stir at −78 oC for 35 min when determined complete by TLC 
(UV, anisaldehyde stain).  The reaction was then quenched by the addition of acetone (3 
ml) which was pre-cooled to match the temp of the reaction.  The reaction was allowed to 
stir for 5 min then warmed to room temp at which time aqueous 20 wt% Na, K-tartrate 
(30 ml) was added with rapid stirring.  This two phase solution was allowed to stir 
rapidly until the phases separated easily upon stopping the stirring.  The layers were 
separated and the aqueous layer was extracted with Et2O (3 x 15ml).  The organics were 
collected and washed with 15 ml of brine and dried over Na2SO4 followed by 
concentration en vacuo.  This procedure required no further purification and produced 
allylic alcohol 13 (1.623 g, 89%) as a clear, colorless oil.  Spectral data gave a 
satisfactory match to previous reports.27  1H NMR (CDCl3, 270 MHz) δ 5.64 (m, 2H), 
4.10 (dd, J = 5.4, 5.4 Hz, 2H), 3.27 (dd, J = 5.4, 4.3  Hz, 1H), 2.36 (m, 1H), 1.73 (m, 1H), 
1.24 (dd, J = 5.7, 5.7 Hz, OH, 1H), 0.99 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.87 (d, J = 6.7 
Hz, 3H), 0.86 (d, J = 6.7 Hz, 3H), 0.03 (s, 3H), 0.02 (s, 3H). [α]D24  = −13.5 (c = 2.6, 
CH2Cl2); 
 
 
 
 31 
(−)-(E,4S,5S)-5-(tert-butyldimethylsilyloxy)-4,6-dimethylhept-2-enal (6): 
OTBS O
H
 
The allylic alcohol 13 (1.33 g, 4.89) was dissolved in CH2Cl2 (15 ml) followed by the 
addition of 10 mass equivalent of MnO2 (13.3 g) in one portion.  The reaction was 
allowed to stir at RT for 4 days until determined complete by TLC (UV, KMnO4).  The 
mixture was filtered through celite and concentrated en vacuo.  This procedure required 
no further purification and produced enal 6 (987 mg, 87.5%) as a clear, colorless oil.  
Spectral data gave a satisfactory match to previous reports.28 1H NMR (CDCl3, 270 MHz) 
δ 9.53 (dd, J = 7.9 Hz, 1H), 6.92 (dd, J = 15.8, 7.9 Hz, 1H), 6.13 (d, J = 15.8, 8.1 Hz, 
1H), 3.45 (dd, J = 4.9, 4.9  Hz, 1H), 2.64 (m, 1H), 1.73 (m, 1H), 1.08 (d, J = 6.9 Hz, 3H), 
0.91 (s, 9H), 0.89 (d, J = 6.7 Hz, 3H), 0.82 (d, J = 6.7 Hz, 3H), 0.09 (s, 3H), 0.04 (s, 3H). 
[α]D24 =  − 48.4 (c = 1.2, CH2Cl2). 
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(−)-(E,4R,7S,8S)-8-(tert-butyldimethylsilyloxy)-7,9-dimethyldeca-1,5-dien-4-ol (10a): 
OTBS OH
 
A solution of enal 6 (6.00 g, 22.2 mmol) in CH2Cl2 (75 mL) was cooled to −15o C in a 
salt-ice bath and was added via cannula to a separate RBF containing allyl silane [(S,S)-
Leighton reagent] (28.6 g, 51.48 mmol) in CH2Cl2 (75 mL) at −15o C.  The reaction was 
then placed in the freezer and allowed to react for 5 days.  The reaction mixture was then 
diluted with EtOAc (100 mL) and filtered through a plug of Celite to remove the white 
precipitate that had formed after several minutes stirring with EtOAc.  The filtrate was 
then washed with sat. aq. NaHCO3 (75 mL) and brine (75 mL).  The organics were then 
dried over Na2SO4.  After concentration the crude mixture was purified immediately by 
silica gel column chromatography (5% EtOAc/Hexanes) to yield 5.80 g (84%) of 
acetonide 10a.  The minor isomer (from the ca 10% enantiomer) was isolated in a 
mixture with other products.  Spectral data gave a satisfactory match to previous 
reports.29 Rf = 0.60 (1:4 EtOAc:Hexanes), [α]25 D = − 13 (c = 0.9, CH2Cl2); IR (neat, cm-
1) 3345 (br), 2960, 2930, 2856, 1634, 1473, 1260, 1113, 1055, 1005, 975, 856, 775; 1H 
NMR (CDCl3, 600 MHz) δ 5.79 (m, 1H), 5.62 (dd, J = 15.0, 7.8 Hz, 1H), 5.44 (dd, J = 
15.0, 7.2 Hz, 1H), 5.12 (m, 2H), 4.12 (m, 1H), 3.25 (dd, J = 6.0, 4.2 Hz, 1H), 2.30  (m, 
3H), 1.73 (m, 1H), 1.56 (d, J = 4.0 Hz, 1H), 0.98 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.87 
(d,  J = 6.7 Hz, 3H), 0.83 (d, J = 6.7 Hz, 3H), 0.03 (s, 6H); 13C NMR (CDCl3, 150 MHz) 
δ 136.1, 134.4, 131.1, 117.9, 80.9, 72.2, 42.0, 41.3, 31.5, 26.0, 20.5, 17.4, 16.7, -3.5, -3.8. 
HRMS (ESI) calcd for [C18H36O2Si + Na]+: 335.2382  Found: 335.2385. 
 
(4S,7S,8S,E)-8-(tert-butyldimethylsilyloxy)-7,9-dimethyldeca-1,5-dien-4-ol (10b): 
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OTBS OH
 
 
A solution of enal 6 (0.07 g, 0.259 mmol) in CH2Cl2 (5 mL) was cooled to −15o C in a 
salt-ice bath and was added via cannula to a separate RBF containing allyl silane [(R,R)-
Leighton reagent] (0.286 g, 0.517 mmol) in CH2Cl2 (5 mL) at −15o C.  The reaction was 
then placed in the freezer and allowed to react for 3 days.  The reaction mixture was then 
diluted with EtOAc (50 mL) and filtered through a plug of Celite to remove the white 
precipitate that had formed after several minutes stirring with EtOAc.  The filtrate was 
then washed with sat. aq. NaHCO3 (20 mL) and brine (25 mL).  The organics were then 
dried over Na2SO4.  After concentration the crude mixture was purified immediately by 
silica gel column chromatography (5% EtOAc/Hexanes) to yield 0.080g (86%) of 
acetonide 10b.  The minor isomer (from the ca 10% enantiomer) was isolated in a 
mixture with other products.  Spectral data gave a satisfactory match to previous 
reports.25 Rf = 0.60 (1:4 EtOAc:Hexanes), [α]25 D = − 13 (c = 0.9, CH2Cl2); IR (neat, cm-
1) 3353 (br), 2957, 2929, 2857, 1642, 1472, 1251, 1112, 1050, 1005, 974, 857, 834, 771; 
1H NMR (CDCl3, 600 MHz) δ 5.80 (m, 1H), 5.62 (dd, J = 15.0, 7.8 Hz, 1H), 5.44 (dd, J 
= 15.0, 7.2 Hz, 1H), 5.12 (m, 2H), 4.12 (m, 1H), 3.25 (dd, J = 6.0, 4.2 Hz, 1H), 2.30  (m, 
3H), 1.73 (m, 1H), 1.56 (d, J = 4.0 Hz, 1H), 0.98 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.87 
(d,  J = 6.7 Hz, 3H), 0.83 (d, J = 6.7 Hz, 3H), 0.03 (s, 6H); 13C NMR (CDCl3, 150 MHz) 
δ 135.9, 134.3, 130.7, 118.0, 80.7, 71.8, 42.0, 40.7, 31.6, 26.1, 20.5, 18.4, 17.4, 16.4. 
 
(−)-Ethyl 2-((2R,4S,6R)-6-((E,3S,4S)-4-(tert-butyldimethylsilyloxy)-3,5-dimethylhex-
1-enyl)-2-phenyl-1,3-dioxan-4-yl)acetate (11): 
 34 
OTBS O
OEt
OO
Ph
 
 To a solution of the alcohol (5.2 g, 13.5 mmol) and benzaldehyde (1.51 mL, 15.0 mmol) 
in THF (42 mL) was added the t-BuOK (151 mg, 1.35 mmol).  The reaction mixture was 
stirred for 15 min.  The addition of t-BuOK and benzaldehyde was repeated for 3 times 
every 15 min and then the reaction mixture was quenched with 35 mL pH=7 buffer 
solution, extracted with Et2O (3 x 100 mL), dried (Na2SO4), and concentrated under 
reduced pressure.  The crude product was purified using silica gel flash chromatography 
eluting with 10% EtOAc/hexane to give 4.23 g (8.64 mmol, 64%) of colorless oil acetal 
11.  Rf = 0.70 (1:4 EtOAc:Hexanes), [α]25 D = − 8 (c = 1.0, CH2Cl2); IR (neat, cm-1) 2957, 
2929, 2856, 1736, 1472, 1370, 1339, 1251, 1149, 1095, 1051, 1025, 974, 938, 857, 835, 
772, 697; 1H NMR (CDCl3, 600 MHz) δ 7.50 (m, 2H), 7.33 (m, 3H), 5.76 (dd, J = 15.0, 
7.8 Hz, 1H), 5.60 (s, 1H), 5.50 (dd, J = 15.0, 7.2 Hz, 1H), 4.34 (m, 2H), 4.17 (q, J = 7.2 
Hz, 2H), 3.29 (dd, J = 5.4, 4.2 Hz, 1H), 2.73 (dd, J = 15.6, 7.2 Hz, 1H), 2.51 (dd, J = 
15.6, 6.0 Hz, 1H), 2.34 (m, 1H), 1.75 (m, 1H), 1.74 (m, 1H), 1.56 (m, 1H), 1.26 (t, J = 
7.2 Hz, 3H), 1.00 (d, J = 6.6 Hz, 3H), 0.91 (s, 9H), 0.89 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 
6.6 Hz, 3H), 0.04 (s, 6H); 13C NMR (CDCl3, 150 MHz) δ 170.7, 138.4, 136.5, 128.6, 
128.2, 128.1, 126.1, 100.6, 80.7, 77.2, 73.1, 60.5, 41.0, 40.7, 36.7, 31.6, 26.1, 20.5, 18.4, 
17.6, 15.9, 14.1, -3.5, -3.7; HRMS (ESI) calcd for [C28H46O5Si + Na]+: 513.3006  Found: 
513.2982. 
(−)-2-((2R,4S,6R)-6-((E,3S,4S)-4-(tert-butyldimethylsilyloxy)-3,5-dimethylhex-1-
enyl)-2-phenyl-1,3-dioxan-4-yl)acetaldehyde (15): 
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To a solution of alcohol 14 (40mg, 0.089mmol) is stirred at room temperature in DCM 
(3mL) under an inert atmosphere and the periodinane (99mg, 0.134mmol) is added in one 
portion. The reaction is stirred until completion (TLC, about 2 hours) then quenched with 
sodium thiosulphate (saturated solution), extracted 3 times with ethyl acetate, washed 
with brine, dried over magnesium sulphate, filtered and concentrated in vacuum. The 
curde product was purified using silica gel flash chromatography eluting with 30% 
EtOAc/Hexanes to yield about 36mg (90%) of colorless oil aldehyde 15. Rf  = 0.50 (1:4 
EtOAc:Hexanes), [α]25D = − 8.4 (c = 1.0, CH2Cl2); IR (neat, cm-1) 2957, 2929, 2856, 
1724, 1472, 1385 1360, 1251, 1183, 1096, 1050, 1022, 973, 938, 855, 835, 771, 697 672; 
1H NMR (CDCl3, 600 MHz) δ 9.86 (t, J = 1.8 Hz, 1H), 7.50 (m, 2H), 7.33 (m, 3H), 5.76 
(dd, J = 15.6, 7.8 Hz, 1H), 5.60 (s, 1H), 5.51 (dd, J = 15.6, 5.4 Hz, 1H), 4.43 (m, 1H), 
4.36 (m, 1H), 3.29 (dd, J = 5.4, 4.2 Hz, 1H), 2.82 (dd, J = 16.8, 7.2 Hz, 1H), 2.62 (dd, J = 
16.8, 5.4 Hz, 1H), 2.34 (m, 1H), 1.74 (m, 1H), 1.72 (m, 1H), 1.60 (m, 1H), 1.00 (d, J = 
7.2 Hz, 3H), 0.91 (s, 9H), 0.89 (d, J = 7.2 Hz, 3H), 0.85 (d, J = 7.2 Hz, 3H), 0.04 (s, 6H); 
13C NMR (CDCl3, 150 MHz) δ 200.2, 138.2, 136.7, 128.7, 128.1, 128.0, 126.1, 100.7, 
80.7, 77.2, 71.7, 49.3, 40.7, 36.8, 31.6, 26.1, 20.5, 18.4, 17.6, 15.9, -3.5, -3.7; HRMS 
(ESI) calcd for [C26H42O4Si + Na]+: 469.2745  Found: 469.2750. 
(−)-(S)-1-((2R,4R,6R)-6-((E,3S,4S)-4-(tert-butyldimethylsilyloxy)-3,5-dimethylhex-1-
enyl)-2-phenyl-1,3-dioxan-4-yl)pent-4-en-2-ol (12a).  
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A solution of aldehyde 15 (10 mg, 0.022 mmol) in CH2Cl2 (1 mL) was cooled to −15o C 
in a salt-ice bath and was added via cannula to a separate RBF containing allyl silane 
[(R,R)-Leighton reagent] (16 mg, 0.067 mmol) in CH2Cl2 (1 mL) at −15o C.  The reaction 
was then placed in the freezer and allowed to react for 2 h.  The reaction mixture was 
then diluted with EtOAc (5 mL) and filtered through a plug of Celite to remove the white 
precipitate that had formed after several minutes stirring with EtOAc.  The filtrate was 
then washed with sat. aq. NaHCO3 (10 mL) and brine (10 mL).  The organics were then 
dried over Na2SO4.  After concentration the crude mixture was purified immediately by 
silica gel column chromatography (10% EtOAc/5% MeOH/Hexanes) to yield 10 mg 
(90%) of homoallylic alcohol 12a. [α]25D = − 2.3 (c = 1.0, CH2Cl2); IR (neat, cm-1) 3441 
(br), 2955, 2930, 2856, 1472, 1461, 1385, 1337, 1251, 1215, 1097, 1052, 1022, 974, 914, 
857, 835, 772, 697, 673; 1H NMR (CDCl3, 600 MHz) δ 7.50 (m, 2H), 7.33 (m, 3H), 5.84 
(m, 1H), 5.75 (dd, J = 15.6, 7.8 Hz, 1H), 5.59 (s, 1H), 5.52 (dd, J = 15.6, 6.6 Hz, 1H), 
5.13 (m, 2H), 4.33 (ddd, J = 9.6, 6.6, 1.8 Hz, 1H), 4.20 (dddd, J = 10.8, 8.4, 3.0, 3.0 Hz, 
1H), 4.04 (m, 1H), 3.29 (dd, J = 5.4, 4.2 Hz, 1H), 2.34 (m, 1H), 2.26 (m, 2H), 1.71 (m, 
4H), 1.61 (m, 1H), 0.99 (d, J = 6.6 Hz, 3H), 0.91 (s, 9H), 0.89 (d, J = 7.2 Hz, 3H), 0.85 
(d, J = 6.6 Hz, 3H), 0.04 (s, 6H); 13C NMR (CDCl3, 150 MHz) δ 138.6, 136.4, 134.7, 
128.6, 128.4, 128.1, 126.1, 118.0, 100.7, 80.7, 77.5, 74.0, 67.0, 42.2, 42.1, 40.7, 37.0, 
31.6, 26.1, 20.5, 18.4, 17.6, 15.9, -3.5, -3.7; HRMS (ESI) calcd for [C29H48O4Si + Na]+: 
511.3214  Found: 511.3220. 
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